Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepke

Showing results (261-270 of 316) with videos related to

Pageof 32
Sort By:
Pulmonary Circulation|May 11, 2013
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertensionLuke S G E Howard, Geoffrey M J Watson, John Wharton, et al.
American Journal of Respiratory and Critical Care Medicine|February 23, 2008
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertensionRobin Condliffe, David G Kiely, J Simon R Gibbs, et al.
BMC Pulmonary Medicine|December 29, 2017
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access studyVallerie V McLaughlin, Pavel Jansa, Jens E Nielsen-Kudsk, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2024
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary EmbolismJames Liley, Michael Newnham, Marta Bleda, et al.
JACC. Basic to Translational Science|May 29, 2026
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
ERJ Open Research|December 10, 2025
Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertensionMarion Delcroix, Irene M Lang, Andrea M D'Armini, et al.
Pageof 32

Showing results (261-270 of 316) with videos related to

Sort By:
Pageof 32
Pulmonary Circulation|May 11, 2013
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertensionLuke S G E Howard, Geoffrey M J Watson, John Wharton, et al.
American Journal of Respiratory and Critical Care Medicine|February 23, 2008
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertensionRobin Condliffe, David G Kiely, J Simon R Gibbs, et al.
BMC Pulmonary Medicine|December 29, 2017
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access studyVallerie V McLaughlin, Pavel Jansa, Jens E Nielsen-Kudsk, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2024
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary EmbolismJames Liley, Michael Newnham, Marta Bleda, et al.
JACC. Basic to Translational Science|May 29, 2026
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial HypertensionChristopher J Rhodes, John Wharton, Emilia M Swietlik, et al.
ERJ Open Research|December 10, 2025
Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertensionMarion Delcroix, Irene M Lang, Andrea M D'Armini, et al.
Pageof 32